economist semaglutide Soumaya Keynes and @claerb discuss the results of a recent study on the impact of GLP-1 weight loss drugs on women — and whether it was weight loss or increased confidence that helped unemployed women Ozempic's biggest side effect: Turning

The peptide's enhancement of antioxidant enzyme activity and reduction of pro-inflammatory cytokines provides cellular protection crucial for maintaining cognitive function during aging

Key differences include scale, regulatory approach, and transparency

The Food and Drug Administration (FDA) has not approved Ozempic for weight loss

Evidence is promising but pre-clinical

Accessed at www.uclahealth.org/news/article/semaglutide-weight-loss-what-you-need-know

Ethics declarations Competing interests Through M.H.H.K., the VU University Medical Center has received research grants from AstraZeneca, Boehringer Ingelheim, Novo Nordisk and Sanofi